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to the Editor: Tricuspid regurgitation (TR) is common in
atients with late-stage myocardial and valvular heart disease.
evere TR leads to a decrease in cardiac output (CO), and
ignificant symptoms of right heart failure develop, such as
eripheral edema and congestive hepatosplenomegaly. Surgical
orrection with valve repair or replacement carries a high
perative mortality risk and is therefore not routinely offered to
any patients (1).
To date, no percutaneous approach to TR exists in clinical practice,
nd only limited experimental data have been reported (2,3). Boud-
emline et al. (2) first described a catheter-based approach by implant-
ng a double-disc self-expanding stent with a bovine jugular valve into
he tricuspid annulus, and thus demonstrated the technical feasibility
f this concept. However, several difficulties related to this orthotopic
pproach, including the problem of sufficient fixation of the valve in
he highly dynamic tricuspid annulus, were observed. In human
atients, in whom TR is often secondary to right heart dilation, this
pproach poses even further challenges.
The objective of our study was to evaluate the concept of
eterotopic valve implantation in a central venous position for
artial or full replacement of tricuspid valve function. We therefore
esigned a self-expandable heart valve manufactured with a tubular
itinol stent (diameter 26 and 28 mm) and mounted with a porcine
ulmonary valve. The device was equipped with radiopaque
lements to facilitate visualization under fluoroscopy. For implan-
ation, the valves were loaded into a flexible 21-F delivery catheter
esigned for the purpose of this study (Fig. 1A). All procedures
ere approved by the local ethics committee.
Eight female sheep (64  6 kg) were included in this study for
oncept investigation with the first-generation device. The animals
ere housed and fed according to the National Institutes of Health
uide for the Care and Use of Laboratory Animals federal guidelines
National Institutes of Health publication 85-23, revised 1985). After
he start of anesthesia, right heart catheterization was performed with
5-F pigtail catheter from the right femoral vein to establish baseline
emodynamics. Right ventricular (RV) and venous angiography was
erformed to define the anatomy of the superior vena cava (SVC) and
nferior vena cava (IVC) and the RV. The CO was measured by a
hermodilution technique with a PiCCO catheter (Pulsion Medical
ystems AG,Munich, Germany) positioned in the left femoral artery.
hree repetitive measurements were performed at each time point to
ncrease reliability.
After surgical preparation of the right internal jugular vein, a
.07-inch wire blade was introduced into the RV under fluoroscopy,
nd tricuspid chordae and leaflets were cut by repeated transvalvular
ullback of the device. Severe TR was confirmed by the presence of a
rominent ventricular wave in right atrial and IVC pressure record-
ngs and by RV angiography. The implantation catheter was then
dvanced from the jugular vein over a central guidewire, and stepwise
mplantation of the IVC valve (28 mm) and the SVC valve (26 mm) vas performed. Both devices were deployed approximately 20 mm
rom the atrial orifice of the IVC and SVC.
Hemodynamic parameters including IVC pressure, right atrial
ressure, and CO were measured at baseline, after creation of TR,
fter implantation of each valve, and 1 h post-implantation. Valve
unction was evaluated by epicardial echocardiography and angiogra-
hy. An autopsy was performed in all animals to investigate the device
osition and inspect for macroscopic damage or thrombus formation.
ata analysis was performed using a statistical software package
SPSS for Windows, version 15.0, SPSS Inc., Chicago, Illinois).
omparisons were performed with the Student t test. Statistical
ifferences were considered to be significant for values of p  0.05.
In all animals, TR was successfully created and resulted in a
ignificant decrease of CO from 5.1  1.8 l/min to 3.0  1.2
/min. A prominent ventricular wave in the RA and the IVC was
ecorded with an increase of pressure from 8.4  3.0 mm Hg and
.3  3.3 mm Hg to 16.0  2.4 mm Hg and 15.8  2.6 mm Hg,
espectively. Device implantation was then performed as described
reviously. The IVC valve was successfully delivered in all sheep.
n 1 animal, the SVC valve was deployed too low in the SVC and
igrated into the right atrium after release.
After implantation of the IVC valve, a significant reduction of
he ventricular wave in the IVC was observed (IVC ventricular
ave 13.5  2.9 mm Hg). After implantation of both valves, CO
ncreased significantly to 4.4  0.8 l/min. The y-descent in the
VC decreased significantly compared with the corresponding
trial value (IVC y-descent 11.0  2.2 mm Hg vs. RA y-descent
.7  2.4 mm Hg). During the 1-h observation period, all
emodynamic parameters remained unchanged (at 1 h: CO 5.0 
.4 mm Hg, IVC ventricular wave 14.0  3.7 mm Hg, RA
entricular wave 15.5  2.6 mm Hg).
Angiographic and echocardiographic evaluation showed func-
ioning valves in SVC and IVC positions. No severe valvular or
aravalvular leakage was observed in any of the successfully
mplanted valves. Macroscopic inspection at autopsy confirmed
tructural damage of the native tricuspid valve by rupture of
hordae and leaflets. Appropriate valve position was verified in
ll cases. The stent valves were very tightly positioned in the
VC and SVC, suggesting no paravalvular leakage macroscop-
cally (Figs. 1B and 1C). In 1 animal, atrial migration of the
VC valve had occurred, resulting in a hemopericardium caused
y perforation of the atrial wall by sharp elements of the stent.
Multiple transcatheter approaches for valvular heart disease
ave been developed recently. However, no interventional tech-
ique is yet available to treat TR. A percutaneous approach to TR
ould broaden the therapeutic options and offer treatment in a
everely ill group of patients with frequent multiple comorbidities.
n this experimental study, we evaluate the concept of heterotopic
ricuspid valve replacement via implantation of self-expanding
alves into the IVC and SVC. The hemodynamic effects of the
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February 2, 2010:499–506eterotopic valves were shown by an increase of CO and a decrease
f venous regurgitation in an animal model of acute TR. Valve
unction was confirmed by echocardiography and angiography.
Compared with orthotopic valve implantation, this approach al-
ows sufficient valve fixation and carries a potentially lower risk of
njury to cardiac structures by avoiding the introduction of foreign
aterial in the RV inflow tract. Except for 1 case of device migration,
o further complications associated with the implantation and func-
ion of the valves were observed in this short-term study. Catheter
Figure 1 Percutaneous Tricuspid Valve Replacement
(A) Porcine pulmonary valves were mounted to self-expanding nitinol stents of
28 or 26 mm in diameter. The devices were implanted using a 21-F delivery
catheter. (B) Macroscopic specimen showing the position of the valved stent
in the superior vena cava (SVC) (highlighted area). (C) Valve position in the
SVC and inferior vena cava (IVC) after opening of the right atrium (RA) and right
ventricular (RV) inflow tract. *Ruptured leaflets and chordae of tricuspid valve.
CS  coronary sinus; RAA  right atrial appendage.ntroduction, valve deployment, and fixation were straightforward.
hich the investigators found significant chronobiological vari-
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pSeveral limitations exist and should be considered when applying
his concept to human patients. First, TR in human patients is often
econdary to annular dilation, with substantially higher venous pres-
ures. Thus, this animal model of acute TR only partially represents
he hemodynamic conditions in chronic TR. Second, anatomic
ifferences should be considered because the human IVC is shorter
han that in sheep, with inflow of hepatic veins close to the right
trium. These differences require further development of the device
nd will be surmountable with evolving technology. Third, hetero-
opic valve replacement reduces venous regurgitation; however, RV
nd atrial volume overload persist. The implications on cardiac and
epatic function and potential deleterious effects are unknown, and
urther studies are currently being performed to evaluate long-term
ollow-up. In conclusion, the concept of heterotopic valve implanta-
ion is feasible and has the potential to broaden the therapeutic
ptions for patients with tricuspid valve disease.
Alexander Lauten, MD
Friedrich-Schiller University Jena
ardiology, Angiology, Pneumology and Intensive Care
rlanger Allee 101
7747 Jena
ermany
-mail: alexander.lauten@med.uni-jena.de
ans R. Figulla, MD
hristoph Willich, MS
hristian Jung, MD
ilma Rademacher, MD
arald Schubert, MD
arkus Ferrari, MD
doi:10.1016/j.jacc.2009.09.034
lease note: This study was supported by research grants from the Federal Ministry of
ducation and Research and by grants from JenaValve Technology Inc., Wilmington,
elaware. Drs. Ferrari and Figulla are members of the scientific board of and own shares
f JenaValve.
EFERENCES
. Filsoufi F, Anyanwu AC, Salzberg SP, Frankel T, Cohn LH, Adams
DH. Long-term outcomes of tricuspid valve replacement in the current
era. Ann Thorac Surg 2005;80:845–50.
. Boudjemline Y, Agnoletti G, Bonnet D, et al. Steps toward the
percutaneous replacement of atrioventricular valves: an experimental
study. J Am Coll Cardiol 2005;46:360–5.
. Bai Y, Zong GJ, Wang HR, et al. An integrated pericardial valved stent
special for percutaneous tricuspid implantation: an animal feasibility
study. J Surg Res 2008 Nov 29 [E-pub ahead of print].Letters to the Editorccurrence of
ako-Tsubo Cardiomyopathy
nd Chronobiological Variation
e read with great interest the paper by Citro et al. (1), intions in Tako-Tsubo cardiomyopathy (TTC) occurrence. In
heir large series, TTC was most frequently found in summer
nd in the morning.
We reviewed our cases of TTC from January 2000 to
ecember 2008. We classified our patients (month, season, and
ime of symptom) according to the method of Citro et al. (1),
nd we surprisingly found differing results. In our series of
atients (n  51 [50 women], mean age 71  11 years), the
